Castleman Disease Research Paper

used to treat unicentric Castleman disease, especially if the affected lymph nodes cannot be removed completely with surgery. Radiation can also be used as part of the treatment for multicentric Castleman’s disease. This treatment may also be combined with chemotherapy to cure the more aggressive multicentric Castleman’s disease (What Is Castleman Disease).

After Treatment

Frequent follow-up exams are very important for several years after the treatment is finished. The doctors will continue to watch for signs of recurrent disease, as well as for short-term and long-term side effects of treatment. It is important to report any new symptoms to the doctor right away, so that relapse or side effects can be treated. Checkups usually include careful

It is a disease that looks like cancer due to the growths that form on the lymph nodes inside of the body. The many different categories also make Castleman’s disease unique. Multicentric, unicentric, hyaline-vascular, and plasma cell each have individual traits that can combine with each other to make the disease worse. With the varying categories creates many different symptoms that can make the disease more obvious or almost unknown. The cause of Castleman’s disease is not known but there are links with other immune system issues that might provide an answer in the years to come. But without a known cause doctors are still able to diagnosis people with various tests. Some of these tests will be just physical examinations while others maybe a scan made by a machine. After diagnosis patients will need to be treated with the choice of medication or surgery. Surgery is recommended for those with unicentric Castleman’s disease because it is only one mass located in one area of the body. Medication is better for those with multicentric Castleman’s disease because surgery cannot effectively remove all of the tumors. After treatment is over patients will need to have check-ups for the next five or more years to make sure none of the symptoms or masses come back. If treated properly over 90 percent will survive, but those with preexisting conditions may have a lower rate around 50 percent or lower (Castleman